Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
BTG3
Introduction
Protein BTG3 is a protein that in humans is encoded by the BTG3 gene.[1][2]
The protein encoded by this gene is a member of the BTG/Tob family. This family has structurally related proteins that appear to have antiproliferative properties. This encoded protein might play a role in neurogenesis in the central nervous system.[2]
References
References
- ↑ Yoshida Y, Matsuda S, Ikematsu N, Kawamura-Tsuzuku J, Inazawa J, Umemori H, Yamamoto T (Jun 1998). “ANA, a novel member of Tob/BTG1 family, is expressed in the ventricular zone of the developing central nervous system”. Oncogene. 16 (20): 2687–93. doi:10.1038/sj.onc.1201805. PMID 9632145.
- ↑ 2.0 2.1 “Entrez Gene: BTG3 BTG family, member 3”.
External links
External links
- Human BTG3 genome location and BTG3 gene details page in the UCSC Genome Browser.
Further reading
Further reading
- Matsuda S, Rouault J, Magaud J, Berthet C (2001). “In search of a function for the TIS21/PC3/BTG1/TOB family”. FEBS Lett. 497 (2–3): 67–72. doi:10.1016/S0014-5793(01)02436-X. PMID 11377414.
- Guéhenneux F, Duret L, Callanan MB, et al. (1997). “Cloning of the mouse BTG3 gene and definition of a new gene family (the BTG family) involved in the negative control of the cell cycle”. Leukemia. 11 (3): 370–5. doi:10.1038/sj.leu.2400599. PMID 9067576.
- Hattori M, Fujiyama A, Taylor TD, et al. (2000). “The DNA sequence of human chromosome 21”. Nature. 405 (6784): 311–9. doi:10.1038/35012518. PMID 10830953.
- Birot A, Duret L, Bartholin L, et al. (2000). “Identification and molecular analysis of BANP”. Gene. 253 (2): 189–96. doi:10.1016/S0378-1119(00)00244-4. PMID 10940556.
- Yoshida Y, Hosoda E, Nakamura T, Yamamoto T (2001). “Association of ANA, a member of the antiproliferative Tob family proteins, with a Caf1 component of the CCR4 transcriptional regulatory complex”. Jpn. J. Cancer Res. 92 (6): 592–6. doi:10.1111/j.1349-7006.2001.tb01135.x. PMID 11429045.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). “The Status, Quality, and Expansion of the NIH Full-Length cDNA Project: The Mammalian Gene Collection (MGC)”. Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Rual JF, Venkatesan K, Hao T, et al. (2005). “Towards a proteome-scale map of the human protein-protein interaction network”. Nature. 437 (7062): 1173–8. doi:10.1038/nature04209. PMID 16189514.
- Lim J, Hao T, Shaw C, et al. (2006). “A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration”. Cell. 125 (4): 801–14. doi:10.1016/j.cell.2006.03.032. PMID 16713569.
- Ou YH, Chung PH, Hsu FF, et al. (2007). “The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1”. EMBO J. 26 (17): 3968–80. doi:10.1038/sj.emboj.7601825. PMC 1994125. PMID 17690688.